Aurobindo Integrates Apotex And Prepares For Sandoz
Firm Says Nothing ‘Extraneous’ Holding Up FTC Nod For Sandoz Deal
Executive Summary
Aurobindo believes it has “substantially addressed” all requirements for an FTC go-ahead for its acquisition of Sandoz’s US dermatology and generic oral solids businesses. The integration of the acquired Apotex business in Europe is also shaping up.